While at @DanaFarber, Brian Bruker (now @OHSUKnight) started the personalized medicine revolution with the first targeted cancer drug, imatinib. The first of a series of BCR-ABL inhibitors that made Ph+ #CML a chronic disease. A transformative discovery.